
A consortium of pharmacy trade groups fired back at claims they’re conspiring to “choke off” online information about affordable Canadian drugs, arguing in Manhattan federal court that they’re trying to stop illegal imports, not reduce competition.
“Congress, the courts, and FDA regulations all agree that importation of foreign pharmaceuticals, even for personal use, is illegal,” the groups stated in a March 13 motion. “Plaintiff’s business is built on facilitating the unlawful importation of foreign pharmaceuticals.”
The antitrust lawsuit targets the National Association of Boards of Pharmacy, the Alliance for Safe Online Pharmacies, and Partnership for Safe Medicines.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
South Africa Approves Canal+ MultiChoice Deal
May 21, 2025 by
CPI
WhatsApp Co-Founder Undermines Antitrust Allegations Against Meta in Court Testimony
May 21, 2025 by
CPI
OpenAI Acquires Jony Ive’s io for $6.4B to Pioneer Post-Smartphone Devices
May 21, 2025 by
CPI
Dior Commits €2 Million to Labor Initiatives in Italian Antitrust Settlement
May 21, 2025 by
CPI
Indonesia’s Antitrust Watchdog Probes Potential Risks of Grab-GoTo Merger
May 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Industrial Policy
May 21, 2025 by
CPI
Industrial Strategy and the Role of Competition – Taking a Business Lens
May 21, 2025 by
Marcus Bokkerink
Industrial Policy, Antitrust, and Economic Growth: Some Observations
May 21, 2025 by
David S. Evans
Bolder by Design: Crafting Pro-Competitive Industrial Policies For Complex Challenges
May 21, 2025 by
Antonio Capobianco & Beatriz Marques
Competition-Friendly Industrial Policy
May 21, 2025 by
Philippe Aghion, Mathias Dewatripont & Patrick Legros